Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04548791
Recruitment Status : Recruiting
First Posted : September 16, 2020
Last Update Posted : June 10, 2021
Sponsor:
Information provided by (Responsible Party):
Catalyst Biosciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : March 2022